Want to Join Our Team?
Learn about Blue Matter's innovative work experiences, enriching development opportunities, team-oriented "People First" culture, and a lot more.
Insights
Access our ever-expanding library of thought leadership resources for strategic leaders and professionals in biopharma. It’s full of useful content addressing industry challenges, best practices, therapeutic markets, innovative ideas, and forward-looking insights.
Featured Whitepaper
AI Is Everywhere in Biopharma R&D…Except in the Productivity Numbers: The AI Paradox and How to Overcome It
Learn More >
Featured Whitepaper
5 Key Dynamics Reshaping the Market for Physician-Administered Drugs
Learn More >
Whitepaper
From Promise to Practice: Five Questions Shaping the Future of Psychedelic Medicine
eBook
E-Book: Critical Success Factors for Commercializing Cell & Gene Therapies
Blog
Critical Success Factors for Commercializing Cell & Gene Therapies (10): External Communications – Controlling the Launch Narrative Before the Market Writes Its Own
Blog
From Promise to Practice: Five Questions Shaping the Future of Psychedelic Medicine
Blog
Critical Success Factors for Commercializing Cell & Gene Therapies (9): Commercial Foundation and Infrastructure – Why Launch Success Is Determined Years Before Launch
Blog
Maintaining US Life Science Innovation Leadership Requires Continued Policy Focus, Especially in Rare Disease
Blog
Critical Success Factors for Commercializing Cell & Gene Therapies (8): Internal Training and Cross-Functional Coordination – Higher Science Demands Higher Expertise
Blog
R&D Cost Reporting Under the IRA: The Gap Between What CMS Requires and What Manufacturers Can Produce
Blog
Critical Success Factors for Commercializing Cell & Gene Therapies (7): “White Glove” Patient Support Services & Why Standard Hubs Often Aren’t Enough
Blog
Critical Success Factors for Commercializing Cell & Gene Therapies (6): Elevated Patient Experience and Engagement – Meeting Patients Where They Are
Whitepaper
Exploration of Real-World Data Sources in Latin America, Middle East and North Africa, and Asia Pacific, to Support Oncology Evidence Generation: A Targeted Literature Review and Regional Recommendations
Blog
ASCO 2026: The RAS Revolution Arrives, ADC Era Keeps Expanding, and a New IO Backbone Starts to Take Shape
Blog
Critical Success Factors for Commercializing Cell & Gene Therapies (5): Supplemental Evidence Generation – Why the Data Story Doesn’t End at Approval
Presentation
Strategic Orchestration: Contrasting Portfolio Strategy in Biotech and Big Pharma
Whitepaper
When the Message Gets Lost: How Disconnected Scientific Communications Undermine Physician Confidence and Clinical Adoption
Whitepaper
Boston Biopharma Discussion Synthesis (May 13, 2026)
